Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Labels

March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info: https://youtu.be/811v7RLXP9M
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country
MEBO TMAU TESTING DISCONTINUED
(2012-2017)

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect
rareconnect.org TMAU

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

https://www.meboblog.com/2023/01/denver-tmau-test-survey-tbc-who-it-is.html

Friday, March 28, 2014

Volunteer needed for raising awareness media coverage


Hello

I'm passing on this message from tmau.org.uk. It is an opportunity for UK media coverage.

Thanks, and best wishes

Karen


"Hi there,

I'm a feature writer for an award-winning agency called Talk to the Press
and I have been researcing TMAU.

I would love to get in contact with a female sufferer to talk about their
experiences.

Do you have any case studies or know of anyone who would be willing to talk
to me?

It would just be informal at first and off-the-record, but if they decided
they were happy to go ahead with a story I would send it out to the
national newspapers and women's magazines.

They would receive a fee for their time and it could be a great way to
raise awareness in the national media.

Any help you can give me would be great.

Paisley,, paisley@talktothepress.com"

Karen
Public Relations Director
Raising Awareness Activist


A Public Charity
www.meboresearch.org
www.mebo.com.br/ (em português)
MEBO's Blog (English)
El Blog de MEBO (español)


SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

BORC Conference Call with Dr. Lachmann


We thank Lisa Marie for her proactive work in the TMAU community. Lisa has now reached "over the pond" to set up a conference call with Dr. Robin Lachmann, M.D., who treats most of the TMAU cases in the UK, and who has done a webinar with two of his unit's dieticians, Charlotte Ellerton and Heidi Chan sponsored by RareConnect in November, 2012. Dr. Lachmann has also been interviewed in multiple documentaries in the UK in which sufferers give their testimonies about living with TMAU. Our whole international community extends our profound gratitude to Dr. Lachmann for taking time to educate and guide us as well as for being so proactive in raising awareness.

INFORMATION ABOUT THE CONFERENCE

BORC Conference Call with Dr. Lachmann, PhD Metabolic Unit
Initiated through BORC (A private support group on Facebook)

Conference call With Dr. Robin Lachmann, PhD
Topic Discussions: Trimethylaminuria, Management, & Testing Process.

Speaker: Dr Robin Lachmann PhD FRCP Consultant in Metabolic Medicine Charles Dent Metabolic Unit Box 92 National Hospital for Neurology and Neurosurgery Queen Square London
National Hospital for Neurology and Neurosurgery Queen Square London

April 10, 2014 10AM CDT Time (30 minutes)

If anyone is interested in attending please contact me at lisamariemd@yahoo.com or on facebook (lisa mardis, Birmingham, Alabama.)


http://lisamariemd.wix.com/borc#!campaigns/c1ba5

María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.org
www.meboresearch.org
www.mebo.com.br/ (em português)
MEBO's Blog (English)
El Blog de MEBO (español)


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

Beware of "Snake Oil" Remedies

As I look through the various online forums on body and/or breath odor, I continue to see the same pattern that has existed for years, at least during the last 8 years since I discovered TMAU. It was at that time that I joined CureZone’s Body Odor, and Trimethylaminuria Forums, and some posts were many years older at that time. The rhetoric sounds exactly like today’s rhetoric – sufferers are desperately experimenting with their own bodies with remedies that do not have strong supporting statistics; science has very little answers, except for a few medical conditions that produce body/breath odor, and some basic information about TMAU. It just goes round and round, with some sufferers claiming to have found the cure, which doesn’t seem to work for others…

I most certainly feel for everyone involved. If we take all of this away, what else do we have to hang on to? Sadly, the answer is not very much at all… just hope for research to discover something for some of us in 5, 10, 20 years from now, when our lives have passed us by???

My biggest fear is that sufferers can end up making matters worse instead of better by trying anything and everything. Heck, even something apparently needed by the body, such as iodine, has caused sgaet to develop hyperthyroidism. For years, my doctors have insisted I take calcium every day, which instead of helping me, have produced painful kidney stones. Everything we take has to be digested, metabolized, and eventually eliminated by our cleansing organs, and instead, some things just end up stored in our bodies (in our fat, tissues, bloodstream, etc), which only makes matters worse. A perfect example is Miracle Mineral Supplement (MMS),which many sufferers have taken. I know of the case of a sufferer who ended up in the hospital in serious condition as a result of MMS. Yet, people still post about them in the forums.

I know I paint a bleak picture, and how depressing this is, but I am far more afraid of adverse reactions to makeshift self-experimentation than I am of the depression produced by an odor condition. Since I obviously don’t know of a cure, or even an effective treatment for many, if not most causes of body and breath odor conditions, the following are guidelines I recommend:
  1. The majority of sufferers have a body or breath odor condition, which is not necessarily TMAU. Some sufferers are convinced they have TMAU without testing, when in fact, they might not have it. That is NOT to say that they don’t have a body/breath odor condition, it just means that the TMAU odor-management protocol might not be the answer if they don’t have TMAU. Nonetheless, the protocol might still help some other types of BO/BB conditions, but not all. Therefore, it is best to not assume one has TMAU because it might be more hurtful than helpful in their quest to find a solution.
  2. The majority of sufferers have intermittent odor, detected by some people, though not necessarily by everyone. This is the most difficult condition for which to use a trial and error approach to find a solution. Who is to say that a remedy stopped the odor, when it might have stopped on its own between intermittent flare-ups? Sometimes, a no-odor episode might last a month or two, or even years with or without the remedy being tested. So, how could we really know if it was the tested remedy that worked or not? We can’t know without scientific evidence, which MUST ALWAYS START with a diagnosis, a premise, a starting point, a clear understanding of what the cause(s) of each person’s particular problem is.
  3. When we share with other sufferers about what has worked for us and what has not, we have a duty and responsibility to emphasize to those we are sharing with that perhaps it may not be helpful to others who have a different cause of odor, and that in fact, it might even be potentially harmful to some people. I always refrain from recommending something – anything, without referencing it to a professional and reputable scientific source.

So what do I recommend we do until research is finalized and therapeutics are provided? Stick to what experts in body and breath odor recommend, and EVERYTHING IN MODERATION. Believe it or not, there is a significant amount of information provided by experts, though none have discovered a totally effective treatment or a cure. Try to eat healthy, treat your digestive system, your metabolic system, and all aspects of your body with care – don’t make them go on overdrive by overloading them with unproven, “snake oil” remedies. Always be wary of ideas that claim that one or two remedies are a cure-all for all types of body and breath odor conditions. If there is a remedy or a supplement that you want to try, do so in moderation and listen to your body – not only to the odor, but be vigilant to the effects it may be having on your organs and your health as a whole.

María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.org
www.meboresearch.org
www.mebo.com.br/ (em português)
MEBO's Blog (English)
El Blog de MEBO (español)


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

Wednesday, March 12, 2014

NORD hosts Capitol Hill briefing

Click for more information

NORD hosts Capitol Hill briefing
"Rare Diseases in
Changing Healthcare Landscape"


ALL ARE INVITED!



Join NORD for this Informative and Timely Briefing

The National Organization for Rare Disorders (NORD) will host a Capitol Hill briefing to address topics of particular interest to the rare disease community during this period of significant change in our nation's healthcare environment.

TOPIC: Rare Diseases in a Changing Healthcare Landscape

WHEN: Thursday, March 20, 2014; 2-3:30 p.m. ET

WHERE: U.S. Capitol Visitors Center, Senate Room 212-10

Volunteers to represent MEBO are requested. If you are interested in attending and are near Capitol Hill, please email me at maria.delatorre@meboresearch.org, and I will register you in advance. Due to onsite security in federal buildings, it is necessary to register beforehand to attend this event. Please let me know if you are interested in attending so that I can RSVP online with NORD.


María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.org
www.meboresearch.org
www.mebo.com.br/ (em português)
MEBO's Blog (English)
El Blog de MEBO (español)


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

Message from Founder and Executive Director

MEBO RESEARCH FOUNDER
AND EXECUTIVE DIRECTOR

Many sufferers call the MEBO phone line or email me personally in hopes to receive expert consultation and advice. Please be informed that I am not an expert, and for this reason, I am not available or qualified to give one-on-one counseling to sufferers. This role or function was never my intention when I founded MEBO simply because I am not qualified to do so. As a complement to my Intro Letter post of April 10, 2008, I would like to clarify my position and role in MEBO Research as the Founder and Executive Director.

Since I am not available or qualified to give one-on-one counseling to sufferers, and since MEBO consists of a fully volunteer staff of sufferers and family members, there are no experts available to offer telephone consultations or available to answer large volumes of emails.
As noted in my Intro Letter, I am a mother of a Primary TMAU sufferer who has responded very well to the TMAU odor-management protocol. It is precisely because of my son’s condition that I founded MEBO Research with the sole purpose of promoting research to find a better more reliable treatment, and ultimately a cure. There is no cure at the present time and experts do not foresee a cure in the near future. We can only hope for a better, more reliable treatment to come out of the research currently underway in the United Kingdom and the United States. In the meantime, since Secondary TMAU was not being tested in the US, I found it beneficial to start the MEBO TMAU Test Program.

Since I am not available or qualified to give one-on-one counseling to sufferers, and since MEBO consists of a fully volunteer staff of sufferers and family members, there are no experts available to offer telephone consultations or available to answer large volumes of emails. Therefore, MEBO has gone to great lengths to interviews experts, work with RareConnect to hold webinars given by experts, and to gather literature on Trimethylaminuria and other body and breath odor conditions found in professional journals to post about them in the MEBO Blogs.

In addition, I have put in place a secret, totally private online support group, which consists of a few hundred members that is thriving very well. No one outside the group can see participants’ names, usernames, or pseudonyms associated with MEBO or anything written in this site. In this group, there are sufferers who have many years of experience fine-tuning their respective odor-management techniques, who are very willing to give excellent testimonial to each other and to new members. The topics most discussed in this group are the expert-prescribed odor management protocol and recommendations, and how to face the challenges of school environment and the workplace among other topics. I’ll be happy to invite anyone interested to this group for help and guidance. If interested in being invited, please notify maria@meboresearch.org.

REFERENCES:

María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.org
www.meboresearch.org
www.mebo.com.br/ (em português)
MEBO's Blog (English)
El Blog de MEBO (español)


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

Support Group MEETUP Raleigh-Durham and Surrounding Area

Store Image

The Raleigh/Durham

Food and Diet Support Group

ALL ARE INVITED!


Meet Up Group In Raleigh/Durham and Surrounding Area.


Date/Time:

APRIL 6, 2014 at 1pm EST.


Location:

Barnes & Noble front entrance
Triangle Town Center
5959 Triangle Town Blvd.
Raleigh NC 27616
919-792-2140

Please send a email to kelvinstep@yahoo.com or call 252-758-2838 if you interested in joining the group or with any questions.


See you all there!

One of the most discussed topic in the forums, facebook, emails I receive, and MEBO sites is diet - diet for TMAU sufferers and for non-TMAU sufferers. This is an excellent opportunity to carry out this type of discussion. Come join in!


SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation.

A EURORDIS and NORD Member Organization 

Thursday, March 6, 2014

NORD letter to Congress: Don't Repeal Orphan Drug Tax Credit

MEBO IS A NORD RARE DISEASE PATIENT ORGANIZATION, and as such, have signed onto NORD's letter urging Congress not to repeal the Orphan Drug Tax Credit. As NORD explains,


This issue is critically important to all people affected by rare diseases. The Orphan Drug Tax Credit is a major incentive, created as part of the Orphan Drug Act of 1983, to encourage the development of treatments for people with rare diseases.

A draft tax reform proposal recently released by the leadership of the House Ways & Means Committee would repeal this important tax credit.

It is NORD's position -- on behalf of the entire rare disease community -- that repeal of this tax credit would be anti-patient and anti-public health policy. It would squelch innovative medical research seeking lifesaving therapies for patients who currently have few or no treatment options.

Please join NORD in this important endeavor. Add your organization's name to NORD's letter today to tell Congress the Orphan Drug Tax Credit is important to you!


TEXT OF NORD'S LETTER:


March 2014
The Honorable Ron Wyden, Chairman
U.S. Senate Committee on Finance
Washington, D.C. 20510

The Honorable Orrin G. Hatch, Ranking Member
U.S. Senate Committee on Finance
Washington, D.C. 20510

The Honorable Dave Camp, Chairman
U.S. House Committee on Ways & Means
Washington, D.C. 20515

The Honorable Sander Levin, Ranking Member
U.S. House Committee on Ways & Means
Washington, D.C. 20515

Dear Chairmen Wyden and Camp and Ranking Members Hatch and Levin:

A proposal made public by Chairman Dave Camp (R-Michigan) to amend the Internal Revenue Code of 1986 would repeal the Orphan Drug Tax Credit, one of the most successful tax credits ever passed by Congress, and one that has literally saved thousands of lives. The National Organization for Rare Disorders (NORD) and the {NUMBER} undersigned patient organizations oppose this proposed repeal.

Repeal of this tax credit would be an anti-patient, anti-public health policy, and would squelch medical research and innovation. Repeal would remove one of the major incentives to finding cures and treatments for some of the most challenging diseases.

The credit allows drug manufacturers to claim a tax credit of 50% of certain research costs for orphan drugs (drugs for diseases affecting 200,000 Americans or fewer). Due to this Orphan Drug Tax Credit, as well as other incentives, more research is taking place for orphan drugs than ever before. A third of the new drugs being approved by FDA each year are orphan drugs that benefit from the tax credit. Many if not most of these new drugs may never have been developed if this tax incentive did not exist.

The vast majority of people with a rare disease pray every day for medical progress. About 7,000 rare diseases affect 30 million Americans. Only a few hundred rare diseases have an approved drug.

People in this country with rare diseases deserve to be treated with respect and to retain the hope that, someday, a cure or better treatment will be developed for them. Repealing this tax credit is a signal from the Congress that new treatments for people with rare diseases are unimportant. NORD appeals to Congress to block this proposed repeal and to keep the light of hope on for so many who desperately need life-saving interventions.

Orphan drugs don’t serve just patients with rare diseases. Patients with more common diseases have benefited from the advancements made in orphan drug development. Access to these treatments has saved medical costs by keeping people healthy and out of the hospital and emergency rooms. New treatments promise to save even more.

NORD and the entire rare disease community urge Congress to reconsider the implications of repealing the Orphan Drug Tax Credit as proposed by Chairman Camp, and to keep patients and public health first.

For additional information, contact Diane Edquist Dorman, Vice President, Public Policy, National Organization for Rare Disorders (NORD), ddorman@rarediseases.org, (202) 588-5700 ext. 102.

CC:
Members of the U.S. Senate Committee on Finance
Members of the U.S. House of Representatives Committee on Ways & Means


María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.org
www.meboresearch.org
www.mebo.com.br/ (em português)
MEBO's Blog (English)
El Blog de MEBO (español)


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization